MUSCORIL
MUSCORIL PAIN 20 MG/G GEL 1 PE/AL/PE TUBE OF 60 G
MUSCORIL PAIN 20 MG/G GEL 1 PE/AL/PE TUBE OF 60 G
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
MUSCORIL DOLORE 20 mg/g gel
Diclofenac
What is it and what is it for?
MUSCORIL DOLORE contains the active ingredient diclofenac which belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
MUSCORIL DOLORE is indicated
For adults and adolescents aged 14 years and over
For the local symptomatic treatment of pain associated with acute muscle strains, sprains or bruises following impact trauma, such as sports injuries and accidents.
For adolescents aged 14 years and over, the medicine is indicated for short-term treatment.
What you need to know before taking the medicine
Do not use MUSCORIL DOLORE
- if you are allergic to diclofenac or any of the other ingredients of this medicine (listed in section 6);
- if you have developed asthma attacks, hives, runny nose (acute rhinitis) after taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs (NSAIDs);
- on open wounds, inflammations or infections of the skin, on eczema or on mucous membranes;
- if you are in the last 3 months of pregnancy (see "Pregnancy and breastfeeding");
- in children and adolescents under 14 years of age.
Warnings and precautions
Talk to your doctor or pharmacist before using MUSCORIL DOLORE.
If you suffer from asthma, allergic rhinitis, swelling of the nasal mucosa (so-called nasal polyps) or chronic obstructive pulmonary disease, chronic respiratory tract infections (especially associated with symptoms similar to allergic rhinitis), you are more susceptible than other patients to asthma attacks (so-called analgesic intolerance/analgesic asthma), local swelling of the skin or mucous membranes (so-called Quincke's edema) and hives.
In these patients, MUSCORIL DOLORE can only be used with certain precautions (emergency preparedness) and under direct medical supervision. The same applies to patients who are also allergic to other substances and experience, for example, skin reactions, itching, or hives.
When MUSCORIL DOLORE is applied to a large area of skin and for a prolonged period, the possibility of systemic side effects associated with the application of MUSCORIL DOLORE cannot be excluded.
Apply MUSCORIL DOLORE only to intact, healthy, and unbroken skin. Avoid contact with eyes and oral mucosa. The gel should not be swallowed.
After applying the gel to the skin, you can use a breathable (non-occlusive) dressing, but first let the gel dry on the skin for a few minutes. Do not use it with occlusive dressings that do not allow air to pass through.
Consult your doctor if symptoms worsen or do not improve within 3-5 days. Discontinue use of MUSCORIL DOLORE if you develop a rash.
Avoid exposure to sunlight, including sunlamps, while using this medicine.
Necessary precautions should be taken to prevent children from touching the area to which the gel is applied.
Children and adolescents
MUSCORIL DOLORE is contraindicated in children and adolescents under 14 years of age.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may be serious. Stop using MUSCORIL DOLORE and contact your doctor immediately:
Rare side effects (may affect up to 1 in 1,000 people)
• Inflammation of the skin with blisters (bullous dermatitis).
Very rare side effects (may affect up to 1 in 10,000 people)
• Asthma;
• Swelling of the face, lips, tongue or throat (angioedema).
Other side effects may occur:
Common (may affect up to 1 in 10 people)
• Rash, redness of the skin (erythema), dermatitis (including contact dermatitis), itching.
Uncommon (may affect up to 1 in 100 people)
• Flaking, skin dehydration, edema.
Very rare (may affect up to 1 in 10,000 people)
• Skin rash with pustules;
• Gastrointestinal disorders;
• Hypersensitivity reactions, including urticaria;
• Skin spots or redness following exposure to sunlight or sunlamps (photosensitivity reaction).
Frequency not known (frequency cannot be estimated from the available data)
• Burning sensation at the application site.
When MUSCORIL DOLORE is applied to a large area of skin and for a prolonged period, the possibility of systemic side effects (e.g. renal, hepatic or gastrointestinal side effects, systemic hypersensitivity reactions) similar to those that may appear after systemic administration of medicinal products containing diclofenac cannot be excluded.
Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.
MUSCORIL
MUSCORIL PAIN 20 MG/G GEL 1 PE/AL/PE TUBE OF 60 G
MUSCORIL PAIN 20 MG/G GEL 1 PE/AL/PE TUBE OF 60 G
Couldn't load pickup availability

Is this your first order?
We offer a hassle-free return policy, so you can shop with confidence. Fast and reliable shipping ensures your products arrive directly to your door. And don't worry about privacy : your data is safe with us. We're here to make your online shopping a stress-free and convenient experience.
Sign up for our newsletter. We only send useful stuff. We promise 😉
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.